Zimmer Biomet Guides FY24 Above Estimates - Update

RTTNews | 512 days ago
Stocktwits
Zimmer Biomet Guides FY24 Above Estimates - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) initiated its adjusted earnings and revenue growth outlook for the full-year 2024, above analysts' estimates.

For fiscal 2024, the company now projects adjusted earnings in a range of $8.00 to $8.15 per share on revenue growth of 4.5 to 5.5 percent from last year on a reported basis, with constant currency revenue growth of 5.0 to 6.0 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.94 per share on revenue growth of 4.3 percent to $7.70 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: ZBH
Stocktwits
read more
Zimmer Biomet Trims FY23 Revenue Growth Outlook - Update

Zimmer Biomet Trims FY23 Revenue Growth Outlook - Update

While reporting financial results for the third quarter on Tuesday, medical technology firm Zimmer Biomet Holdings Inc. (ZBH) reaffirmed its adjusted earnings outlook for the full-year 2023, while trimming annual revenue growth guidance.
RTTNews | 605 days ago
Zimmer Biomet Boosts FY23 Outlook - Update

Zimmer Biomet Boosts FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) raised its adjusted earnings and revenue growth outlook for the full-year 2023.
RTTNews | 794 days ago
UK Construction Sector Contraction Slowest In 6 Months

UK Construction Sector Contraction Slowest In 6 Months

UK construction activity declined at the slowest pace since the current period of contraction began in January, survey results from S&P Global showed on Friday. The headline construction Purchasing Managers' Index rose to 48.8 in June from 47.9 in May. The expected score was 48.6. Any reading below 50.0 indicates an overall reduction in construction activity.
RTTNews | 11 minutes ago
U.S. Dollar Falls On U.S. Tariff Uncertainty

U.S. Dollar Falls On U.S. Tariff Uncertainty

The U.S. dollar weakened against other major currencies in the European session on Friday, as the unpredictable economic policies of U.S. President Donald Trump and the decline in trust in the Federal Reserve, led to the downturn of USD.
RTTNews | 36 minutes ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.